Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis

BACKGROUND: A pooled post hoc responder analysis was performed to assess the clinical benefit of alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist, for the management of postoperative ileus after bowel resection. METHODS: Adult patients who underwent laparotomy for bowel resect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludwig, Kirk, Viscusi, Eugene R., Wolff, Bruce G., Delaney, Conor P., Senagore, Anthony, Techner, Lee
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917559/
https://www.ncbi.nlm.nih.gov/pubmed/20526599
http://dx.doi.org/10.1007/s00268-010-0635-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917559/
https://www.ncbi.nlm.nih.gov/pubmed/20526599
http://dx.doi.org/10.1007/s00268-010-0635-9

Ejemplares similares